WO2023120040A1 - 組成物 - Google Patents
組成物 Download PDFInfo
- Publication number
- WO2023120040A1 WO2023120040A1 PCT/JP2022/043646 JP2022043646W WO2023120040A1 WO 2023120040 A1 WO2023120040 A1 WO 2023120040A1 JP 2022043646 W JP2022043646 W JP 2022043646W WO 2023120040 A1 WO2023120040 A1 WO 2023120040A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- less
- mass
- shell
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/04—Water-soluble compounds
- C11D3/08—Silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/22—Coating
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/12—Water-insoluble compounds
- C11D3/124—Silicon containing, e.g. silica, silex, quartz or glass beads
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/77—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with silicon or compounds thereof
- D06M11/79—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with silicon or compounds thereof with silicon dioxide, silicic acids or their salts
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/005—Compositions containing perfumes; Compositions containing deodorants
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/643—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/12—Processes in which the treating agent is incorporated in microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Definitions
- the present invention relates to a composition containing a capsule containing a functional agent.
- fragrances are used in products such as softeners, laundry detergents, and body detergents for the purpose of adding fragrance to the products themselves, clothes, and the body. At that time, it is required that the fragrance can be stably retained so that the fragrance does not disappear in the product.
- microcapsules that use resin such as melamine as the wall material which has been used for a long time, will fall under the category of microplastics due to the revision of rules based on the heightened social awareness of the environment in the future. Concerned.
- the wall material of silica capsules is an inorganic compound, they are not classified as microplastics.
- Japanese Patent Application Laid-Open No. 2015-128762 describes a core made of one or more organic compounds obtained by a predetermined production method, a first shell that encloses the core and contains silica as a constituent, and a first shell that encloses the first shell.
- a microcapsule having an average particle size of 0.5 ⁇ m or more and 50 ⁇ m or less is disclosed, which has a second shell which is in contact with and contains silica as a constituent.
- Japanese Patent Publication No. 2009-504812 discloses an aqueous liquid detergent and cleaning agent containing a surfactant and further common ingredients of detergents and cleaning agents, said agent comprising at least one capsule, said capsule discloses aqueous liquid detergents and cleaners comprising active ingredients, aluminum silicate and silica in a matrix, wherein the aluminum silicate and silica are present in a ratio of 1:10 to 10:1.
- Japanese National Publication of International Patent Application No. 2011-517323 discloses a perfume carrier system comprising an encapsulated perfume composition, wherein the perfume composition contains an emulsion of a perfume compound in an aqueous medium, and a silicon-containing material.
- a perfume carrier system comprising an encapsulated perfume composition encapsulated within a shell, wherein the shell has an average diameter size of less than 30 micrometers, and a surfactant composition containing the perfume carrier system are disclosed. ing.
- the present invention provides a composition comprising silica capsules encapsulating a functional agent and water and having excellent storage stability at high temperatures.
- the present invention relates to a composition containing the following components (A), (B), and water, wherein the component (B) is contained in the composition separately from the component (A) .
- composition containing silica capsules encapsulating a functional agent and water having excellent storage stability at high temperatures.
- Examples of functional agent-containing silica capsules of component (A) include those having a shell containing silica as a constituent and a core containing a functional agent inside the shell.
- (shell) Component (A) includes those having a shell containing silica as a constituent.
- the shell of component (A) may be one in which part or substantially all of the structure constituting the shell is made of silica as a constituent component.
- silica is preferably produced from raw material silica that produces a silanol compound by hydrolysis of alkoxysilane or the like.
- the shell of the component (A) of the present invention is preferably formed by a sol-gel reaction using alkoxysilane as a precursor.
- the "sol-gel reaction” means a reaction in which alkoxysilane is hydrolyzed and polycondensed to form silica, which is a component of the shell, via sol and gel states. Specifically, for example, tetraalkoxysilane is hydrolyzed, the silanol compound is subjected to dehydration condensation reaction and dealcoholization condensation reaction to form a siloxane oligomer, and the dehydration condensation reaction proceeds to form silica.
- raw material silica examples include at least one selected from the group consisting of silicon tetrachloride, tetraalkoxysilane, alkylalkoxysilane, water glass, and metal silicate. Among them, tetraalkoxysilanes and alkylalkoxysilanes are preferred, and tetraalkoxysilanes are more preferred, from the viewpoint of high-temperature storage stability.
- tetraalkoxysilane examples include tetramethoxysilane, tetraethoxysilane, tetrapropoxysilane, and the like. From the viewpoint of high-temperature storage stability, tetramethoxysilane and tetraethoxysilane are preferred, and tetraethoxysilane is more preferred.
- alkylalkoxysilanes include methyltrimethoxysilane, methyltriethoxysilane, ethyltrimethoxysilane, ethyltriethoxysilane, phenyltrimethoxysilane, phenyltriethoxysilane, dimethyldimethoxysilane, methylphenyldimethoxysilane, dimethyldimethoxysilane.
- These can be used individually by 1 type or in combination of 2 or more types. Condensates and the like of these can also be used.
- the shell of the silica capsule of the present invention may contain an inorganic polymer other than silica as a constituent within a range that does not impair the effects of the present invention.
- the inorganic polymer means a polymer containing an inorganic element. Examples of the inorganic polymer include a polymer consisting only of inorganic elements, a polymer having a main chain consisting only of inorganic elements and having an organic group as a side chain or a substituent, and the like.
- the inorganic polymer is preferably a metal oxide containing a metal element or a metalloid element, more preferably a metal alkoxide [M(OR) x ] as a precursor, and the above-mentioned silica is a polymer formed by a reaction similar to the sol-gel reaction of
- M is a metal or metalloid element
- R is a hydrocarbon radical.
- metal or metalloid elements that constitute metal alkoxides include titanium, zirconium, aluminum, and zinc.
- the shell may have a first shell and a second shell, and the component (A) comprises a first shell enclosing a core containing one or more functional agents and a second shell enclosing the first shell. and a shell. Furthermore, the component (A) of the present invention may have a third shell made of an organic polymer compound in contact with the second shell. Such a multilayer shell is preferable from the viewpoint of high-temperature storage stability because it can retain functional agents such as fragrances for a long period of time.
- the thickness of the shell is preferably 5 nm or more, preferably 20 nm or less, more preferably 15 nm or less, from the viewpoint of high-temperature storage stability.
- the shell should be a dense structure with as few pores as possible from the viewpoint of high-temperature storage stability and long-term retention of the functional agent contained therein. Layers are preferred.
- the thickness of the second shell is preferably 10 nm or more, more preferably 20 nm or more, and preferably 100 nm or less, more preferably 100 nm or less, from the viewpoint of high-temperature storage stability. is 80 nm or less.
- the second shell preferably has a mesoporous structure in which silica is present not only in the direction along the interface with the first shell but also in the thickness direction.
- the "mesoporous structure" in the second shell means that the diameter of pores (so-called mesopores) present in the structure preferably exceeds 2 nm, more preferably 10 nm or more, from the viewpoint of high-temperature storage stability. , more preferably 30 nm or more, and preferably 50 nm or less, more preferably 45 nm or less, still more preferably 40 nm or less. Since the second shell has a mesoporous structure, the component (A) has high mechanical strength.
- the average thickness of the first and second shells of component (A) and the pore diameters of the first and second shells can be measured by transmission electron microscope (TEM) observation. Specifically, the thicknesses of the first and second shells and the pore diameters of the first and second shells are actually measured on photographs under observation with a transmission electron microscope. This operation is performed by changing the field of view five times. From the obtained data, the thickness of the first and second shells and the pore size distribution are determined.
- the standard magnification of the transmission electron microscope is 10,000 to 100,000 times, but it is appropriately adjusted depending on the size of the component (A).
- TEM transmission electron microscope
- JEM-2100 manufactured by JEOL Ltd.
- the core of component (A) of the present invention comprises one or more functional agents.
- Functional agents may be, for example, oil-soluble liquids.
- the component (A) encloses the perfume inside the shell, and when the shell is broken, the perfume is released and emits a fragrance.
- functional agents include perfumes, perfume precursors, oils, antioxidants, cooling agents, warming agents, antibacterial agents, dyes, pigments, UV absorbers, silicones, solvents, and oil-soluble polymers.
- perfumes perfume precursors, oils, antioxidants, cooling agents, warming agents, antibacterial agents, dyes, pigments, UV absorbers, silicones, solvents, and oil-soluble polymers.
- perfumes perfume precursors, oils, antioxidants, cooling agents, warming agents, antibacterial agents, ultraviolet absorbers, and solvents
- perfumes and perfumes One or more selected from the group consisting of precursors can be mentioned.
- Functional agents may also be skin care ingredients such as moisturizers, cosmetic oils, preservatives, antioxidants, insecticidal ingredients and insect repellent ingredients.
- perfumes examples include ⁇ -undecalactone, 2-cyclohexylidene-2-phenylacetonitrile, damascenone, ⁇ -damascone, ⁇ -methyl- ⁇ -(pt-butylphenyl)-propionaldehyde, ⁇ -ionone.
- perfume precursors include compounds that release perfume components by reacting with water.
- a silicate ester compound having an alkoxy component derived from a fragrance alcohol a fatty acid ester compound having an alkoxy component derived from a fragrance alcohol, an acetal compound obtained by the reaction of a carbonyl component derived from a fragrance aldehyde or a fragrance ketone and an alcohol compound, or A hemiacetal compound, a Schiff base compound obtained by reacting a carbonyl component derived from a perfume aldehyde or a perfume ketone with a primary amine compound, a hemiaminal compound or a hydrazone compound obtained by reacting a carbonyl component derived from a perfume aldehyde or a perfume ketone with a hydrazine compound is mentioned.
- perfume precursors include compounds that release perfume components in response to light. Examples thereof include 2-nitrobenzyl ether compounds having an alkoxy component derived from perfume alcohol, ⁇ -ketoester compounds having a carbonyl component derived from perfume aldehydes and perfume ketones, and coumaric acid ester compounds having an alkoxy component derived from perfume alcohol. These perfume precursors may be used as polymers, for example reaction products of some carboxyl groups of polyacrylic acid and perfume alcohols. Among these, a silicate compound having an alkoxy component derived from perfume alcohol is preferable.
- the ClogP value of the functional agent is preferably 2 or more, more preferably 3 or more, still more preferably 4 or more, and preferably 30 or less, more preferably 20 or less, still more preferably 10 or less.
- the encapsulation rate (hereinafter also referred to as "encapsulation rate") of the functional agent in the component (A) is improved.
- the functional agent is a perfume composition containing a plurality of perfumes, the same applies to the above.
- the encapsulation rate (encapsulation rate) can be improved.
- the ClogP value is determined by the method described in A. Leo in "Comprehensive Medicinal Chemistry", Vol.4, (C.
- the oil-water interfacial tension of the functional agent is preferably 7 mN/m or more, more preferably 10 mN/m or more, and still more preferably 13 mN/m or more at 25°C from the viewpoint of retention of the functional agent.
- the oil-water interfacial tension of the functional agent can be measured, for example, with a contact angle meter "DropMaster DM-501" (trade name, manufactured by Kyowa Interface Science Co., Ltd.).
- the volume average particle diameter of component (A) is preferably 0.5 ⁇ m or more, more preferably 0.7 ⁇ m or more, and still more preferably 1 ⁇ m or more, from the viewpoints of blendability in products and retention of functional agents. Yes, and preferably 50 ⁇ m or less, more preferably 10 ⁇ m or less, and even more preferably 5 ⁇ m or less.
- the volume average particle diameter of component (A) can be measured by the method described in Examples. For example, it can be measured using a laser diffraction/scattering particle size distribution analyzer “LA-960” (trade name, manufactured by HORIBA, Ltd.). In that case, the measurement uses a flow cell, the medium is water, and the refractive index is set to 1.40-0i. A dispersion liquid containing the component (A) is added to the flow cell, measurement is performed at a concentration at which the transmittance is around 90%, and the average particle diameter is determined on a volume basis.
- LA-960 laser diffraction/scattering particle
- the component (A) is a component (A) having a first shell and a second shell containing silica as constituent components, and a core containing one or more functional agents inside the first shell
- the ( Component A) can be obtained, for example, by a production method comprising the following steps (1) and (2).
- Step (1) An organic phase containing one or more functional agents and raw material silica (eg, tetraalkoxysilane) was mixed and emulsified in an aqueous phase containing a surfactant (eg, cationic surfactant). Then, a sol-gel reaction is performed under acidic conditions to form a shell to form capsules encapsulating the functional agent.
- a surfactant eg, cationic surfactant
- a raw material silica eg, tetraalkoxysilane
- the component (A) is, for example, It can be obtained by a production method comprising the following steps (1a) and (2a) and, if necessary, further comprising the following step (3a).
- a surfactant e.g., a cationic surfactant
- the "sol-gel reaction" in steps (1) and (2) and steps (1a) and (2a) hydrolyzes and polycondenses raw silica (silica precursor) under acidic conditions. This is a reaction for synthesizing silica for the first and second shells by polymerizing while eliminating alcohol.
- the manufacturing method can be performed with reference to, for example, JP-A-2015-128762 and JP-A-2017-114802.
- the component (A) is usually obtained in a state of being dispersed in water.
- this aqueous dispersion can be used as it is, but in some cases, the component (A) is separated before use. Filtration, centrifugation, or the like can be employed as the separation method.
- the content of the functional agent is, for example, 5 mass% or more, further 10 mass% or more, further 12 mass% or more, and 50 mass% or less, further 45 mass% or less, further 40 mass% or less.
- the content of the functional agent enclosing the component (A) is preferably 0.02% by mass or more, more preferably 0.05% by mass, from the viewpoint of high-temperature storage stability. % or more, more preferably 0.1% by mass or more, still more preferably 0.2% by mass or more, and preferably 10% by mass or less, more preferably 5% by mass or less, still more preferably 1% by mass or less be able to.
- the (B) component is a compound selected from silicic acid and silicates.
- Component (B) includes compounds represented by the following formula (B1). M2O.nSiO2.mH2O ( B1 ) [In the formula, M is an atom selected from an alkali metal atom and a hydrogen atom, n is a number of 1.0 or more and 4.0 or less, and m is a number of 5.0 or more and 50.0 or less. ]
- the alkali metal atom of M includes a sodium atom and a potassium atom.
- n is preferably 1.8 or more and 4.0 or less, more preferably 1.9 or more and 3.5 or less, still more preferably 2.0 or more and 3.3 or less, from the viewpoint of high-temperature storage stability.
- m is preferably 10.0 or more and 48.0 or less, more preferably 11.0 or more and 35.0 or less, and still more preferably 11.5 or more and 30.0 or less.
- the component (B) is preferably sodium silicate (sodium silicate).
- sodium silicate sodium silicate
- commercially available ones such as No. 1 sodium silicate, No. 2 sodium silicate, No. 3 sodium silicate, No. 4 sodium silicate, No. 5 sodium silicate and the like can be used.
- sodium silicate specified in JIS K 1408 can be used.
- component (B) includes the compounds shown in the table below.
- the composition of the present invention preferably contains component (B) in an amount of 0.001% by mass or more, more preferably 0.01% by mass or more, and still more preferably 0.05% by mass. % by mass or more, more preferably 0.15% by mass or more, and preferably 0.5% by mass or less, more preferably 0.4% by mass or less, and even more preferably 0.3% by mass or less.
- the content of component (B) in the composition in the present invention is the content as silicon dioxide (SiO 2 ), and is specifically determined by the method described in Examples below.
- the mass ratio of the content of component (A) as a functional agent to the content of component (B) as silicon dioxide (SiO 2 ) is (B)/(A) is preferably 0.01 or more, more preferably 0.05 or more, still more preferably 0.25 or more, even more preferably 0.75 or more, and preferably 1.0 or less be.
- the component (B) is contained in the composition separately from the component (A), that is, it exists in the composition without being encapsulated in the silica capsule of the component (A).
- the percentages and mass ratios for component (B) described above are based on the amount of component (B) contained in the composition separately from component (A).
- composition of the present invention may further contain the following component (C).
- component (C) excludes the surfactant included in the component (A).
- component (C) from the viewpoint of dispersion stability of the component (A) and other bases in the composition, detergency when used as a detergent, and high-temperature storage stability, (C1) anionic interface
- component (C1)) and (C2) nonionic surfactants are preferred
- component (C2) nonionic surfactants hereinafter referred to as component (C2)
- component (C1) anionic surfactants include sulfonic acid having a hydrocarbon group and its salts, sulfuric acid ester having a hydrocarbon group and its salts, carboxylic acid having a hydrocarbon group and its salts. Examples include salts, and sulfonates having a hydrocarbon group and carboxylates having a hydrocarbon group are preferred.
- the hydrocarbon group may be an alkyl group or an alkenyl group. From the viewpoint of high-temperature storage stability, the number of carbon atoms in the hydrocarbon group is, for example, 3 or more, preferably 7 or more, more preferably 9 or more, still more preferably 11 or more, and preferably 22 or less, more preferably 20 or less.
- salts include monovalent metal salts such as sodium salts and potassium salts, divalent metal salts such as magnesium salts, ammonium salts, organic amine salts such as monoethanolamine salts, diethanolamine salts and triethanolamine salts. , sodium salts are preferred from the viewpoint of high-temperature storage stability.
- Component (C1) is preferably one or more anionic surfactants selected from the following components (c1-1) to (c1-5) from the viewpoint of high-temperature storage stability, and is selected from components (c1-1). More preferred are one or more anionic surfactants.
- (c1-1) component a sulfonic acid represented by the following general formula (c1-1) or a salt thereof R 1 -B-SO 3 M (c1-1) [In formula (c1-1), R 1 represents an alkyl group or alkenyl group having 3 to 21 carbon atoms, B represents a benzene ring, M represents a hydrogen atom, an alkali metal, an alkaline earth metal (1/2 atom), ammonium, or organic ammonium.
- the sulfonic acid group is attached at the ortho-, meta- or para-position relative to R1 , which is attached to B.
- component salt of internal olefin sulfonic acid having 14 to 24 carbon atoms
- component salt of fatty acid having 8 to 20 carbon atoms
- component the following general formula (c1- 4) a sulfuric acid ester or a salt thereof
- R 2 represents an alkyl or alkenyl group having 8 to 22 carbon atoms
- the carbon atom bonded to the oxygen atom is the first carbon atom
- PO is a propyleneoxy group
- EO represents an ethyleneoxy group
- EO and PO may be block or random bonds
- / is a symbol indicating that the bonding order of PO and EO does not matter
- m and n are the average number of added moles, ,
- Component (c1-5) an ⁇ -sulfofatty acid ester represented by the following general formula (c1-5) or a salt thereof R 3 —CH(SO 3 M)COOR 4 (c1-5)
- R 3 represents an alkyl group or alkenyl group having 6 to 20 carbon atoms
- R 4 represents an alkyl group having 1 to 6 carbon atoms
- M represents a hydrogen atom, an alkali metal, Indicates an alkaline earth metal (1/2 atom), ammonium or organic ammonium.
- the number of carbon atoms in R 1 is 3 or more, preferably 5 or more, more preferably 6 or more, still more preferably 7 or more, and 21 or less, preferably 21 or less, from the viewpoint of high-temperature storage stability. It is 20 or less, more preferably 19 or less, still more preferably 18 or less.
- M is preferably an alkali metal or organic ammonium, more preferably sodium, from the viewpoint of high-temperature storage stability.
- the content of component (c1-1) in the present invention is based on the amount of the compound converted to sodium salt.
- (c1-1) component examples include alkyl (4 or more carbon atoms) benzenesulfonic acid and cumenesulfonic acid.
- the number of carbon atoms in the internal olefin sulfonate of component (c1-2) is 14 or more, preferably 16 or more, more preferably 18 or more, and 24 or less, more preferably 22 or less, from the viewpoint of high-temperature storage stability. More preferably, it is 20 or less.
- Component (c1-2) includes, in addition to internal olefinsulfonates, hydroxyalkanesulfonates and olefinsulfonates produced during synthesis.
- Salts of component (c1-2) include alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, ammonium salts and organic ammonium salts such as monoethanolammonium, diethanolammonium and triethanolammonium.
- Alkanol ammonium salts such as From the viewpoint of high-temperature storage stability, alkali metal salts and alkanolammonium salts having 2 to 6 carbon atoms are preferred.
- the content of component (c1-2) in the present invention is based on the amount of the compound converted to potassium salt.
- the number of carbon atoms in the fatty acid of component (c1-3) is 8 or more, preferably 10 or more, more preferably 12 or more, and 20 or less, more preferably 18 or less, and still more preferably 16, from the viewpoint of high-temperature storage stability. It is below.
- the salt of the component (c1-3) includes alkali metal salts, alkaline earth metal (1/2 atom) salts, ammonium salts and organic ammonium salts from the viewpoint of high-temperature storage stability.
- the content of component (c1-3) in the present invention is based on the amount of the compound converted to the acid form (hydrogen atoms).
- component (c1-3) examples include octanoate, decanoate, laurate, myristate, palmitate, stearate, coconut fatty acid salt, palm fatty acid salt, and palm kernel fatty acid salt. be done.
- R 2 preferably has 9 or more carbon atoms, more preferably 10 or more carbon atoms, still more preferably 12 or more carbon atoms, and preferably 18 or less carbon atoms, more preferably 16 carbon atoms, from the viewpoint of high-temperature storage stability. More preferably, it is an alkyl group or alkenyl group of 14 or less. R 2 is preferably an alkyl group, and from the viewpoint of high-temperature storage stability, R 2 is more preferably a linear alkyl group.
- m is preferably 4 or less, more preferably 3 or less, from the viewpoint of high-temperature storage stability.
- n is preferably 0 or more, more preferably 1 or more, still more preferably 2 or more, even more preferably 4 or more, and preferably 10 or less, from the viewpoint of high-temperature storage stability, It is more preferably 8 or less, still more preferably 6 or less.
- M is preferably a hydrogen atom, an alkali metal such as sodium or potassium, an alkaline earth metal such as magnesium or calcium (1/2 atom), or an organic ammonium. is. From the viewpoint of high-temperature storage stability, M is more preferably an alkali metal such as sodium or potassium, an alkanolammonium such as monoethanolammonium or diethanolammonium, and more preferably sodium.
- the content of component (c1-4) in the present invention is based on the amount of the compound converted to sodium salt.
- Specific components (c1-4) include, from the viewpoint of high-temperature storage stability, an alkyl group having 12 to 14 carbon atoms, an average added mole number of propioxy groups of 0 to 4, and an ethyleneoxy group A (polyoxypropylene) polyoxyethylene alkyl ether sulfate ester sodium salt having an average addition mole number of 1 or more and 4 or less is preferable. That is, the component (c1-4) is represented by the general formula (c1-4), wherein R 2 is an alkyl group having 12 to 14 carbon atoms, m is 0 to 4, n is 1 to 4, and M is sodium. Certain compounds are preferred.
- R 3 is preferably an alkyl group or alkenyl having 8 or more, more preferably 10 or more, and preferably 18 or less, more preferably 16 or less, from the viewpoint of high-temperature storage stability. is the base. R 3 is preferably an alkyl group.
- R 4 is an alkyl group having 1 or more, preferably 5 or less, more preferably 4 or less carbon atoms from the viewpoint of high-temperature storage stability.
- M is preferably a hydrogen atom, an alkali metal such as sodium or potassium, an alkaline earth metal such as magnesium or calcium (1/2 atom), or an organic ammonium, from the viewpoint of high-temperature storage stability. is. From the viewpoint of high-temperature storage stability, M is more preferably an alkali metal such as sodium or potassium, an alkanolammonium such as monoethanolammonium or diethanolammonium, and more preferably sodium.
- the content of component (c1-5) in the present invention is based on the amount of the compound converted to sodium salt.
- an ⁇ -sulfo fatty acid in which R 3 is an alkyl group of 11 or more and 14 or less and R 4 is a methyl group Methyl ester sodium or its salts are preferred.
- the nonionic surfactant of component (C2) is sucrose fatty acid ester, glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyalkylene sorbitan fatty acid ester, polyoxyalkylene fatty acid ester, fatty acid alkanolamide or an alkylene thereof.
- examples thereof include oxide adducts, polyoxyalkylene alkyl ethers, alkyl glycosides, polyoxyalkylene alkyl ethers, glyceryl monoethers, etc.
- Polyoxyalkylene ethers and fatty acid methyl ester alkoxylates are preferred.
- Component (C2) includes compounds represented by the following general formula (c2-1) from the viewpoint of high-temperature storage stability.
- R 5 is an alkyl group or alkenyl group having 9 to 18 carbon atoms
- R 6 is a hydrogen atom or a methyl group
- CO is a carbonyl group
- x is the number of 0 or 1
- AO is one or more alkyleneoxy groups selected from alkyleneoxy groups having 2 to 4 carbon atoms;
- the number of carbon atoms in R 5 is 9 or more, preferably 10 or more, more preferably 11 or more, still more preferably 12 or more, and 17 or less, preferably from the viewpoint of high-temperature storage stability. It is 16 or less, more preferably 15 or less, still more preferably 14 or less.
- AO is one or more alkyleneoxy groups selected from alkyleneoxy groups having 2 to 4 carbon atoms from the viewpoint of high-temperature storage stability, and ethyleneoxy and propyleneoxy groups. One or more selected alkyleneoxy groups are preferred.
- x is a number of 0 or 1, preferably 0, from the viewpoint of high-temperature storage stability.
- y is 3 or more, preferably 5 or more, more preferably 7 or more, still more preferably 8 or more, even more preferably 9 or more, still more preferably 9 or more, from the viewpoint of high-temperature storage stability 10 or more and 50 or less, preferably 40 or less, more preferably 30 or less, even more preferably 20 or less, and even more preferably 15 or less.
- R 6 is preferably a hydrogen atom.
- Component (C2) includes, for example, compounds represented by the following general formula (c2-2) from the viewpoint of high-temperature storage stability.
- This compound is a compound in which AO is an ethyleneoxy group and a propyleneoxy group in the above general formula (c2-1).
- R 7 is an alkyl or alkenyl group having 8 to 18 carbon atoms
- EO is an ethyleneoxy group
- PO is a propyleneoxy group
- s, t, and r are the average number of added moles.
- s is 0 or more and 30 or less
- t is 0.1 or more and 5 or less
- r is 0 or more and 30 or less.
- the component (C) in the composition is preferably 1% by mass or more, more preferably 2% by mass or more, still more preferably 5% by mass or more, and even more preferably 10% by mass or more, More preferably 20% by mass or more, preferably 40% by mass or less, more preferably 35% by mass or less, and even more preferably 30% by mass or less.
- (C)/(A) which is the mass ratio of the content as a functional agent contained in component (A) and the content of component (C), is , preferably 0 or more, more preferably 5 or more, still more preferably 10 or more, still more preferably 25 or more, still more preferably 50 or more, still more preferably 90 or more, and preferably 1000 or less, more preferably 700 Below, more preferably 500 or less, still more preferably 200 or less.
- the composition of the present invention can contain a thickener as component (D) in order to suppress separation of the functional agent-encapsulating silica capsules of component (A).
- the thickener included in the (A) component is excluded from the (D) component.
- the content of component (D) in the composition of the present invention is preferably 0.05% by mass or more, more preferably 0.07% by mass or more, from the viewpoints of suppression of separation of component (A) and high-temperature storage stability. , More preferably 0.1% by mass or more, and from the viewpoint of viscosity reduction and high-temperature storage stability of the composition of the present invention, it is preferably 1% by mass or less, more preferably 0.8% by mass or less, and 0.5 % by mass or less is more preferable.
- component (D) a thickener commonly used in compositions containing capsule particles can be used.
- component (D) is selected from, for example, hydrogenated castor oil, acrylic acid-based polymer, polyethylene glycol, acrylamide-based polymer, cellulose nanofiber, polysaccharides, and the like. One or more can be used.
- Component (D) is preferably a thixotropic thickener from the viewpoint of change in liquid viscosity during use.
- composition of the present invention may further contain an organic solvent having a hydroxyl group as component (E) from the viewpoint of stably blending component (C) and high-temperature storage stability.
- component (E) excludes the organic solvent having a hydroxyl group included in the component (A).
- component (E) include the following compounds (E1) to (E6) from the viewpoint of high-temperature storage stability.
- (E1) Monohydric alcohols having 2 to 4 carbon atoms such as ethanol and isopropanol
- E2 Bivalent to hexavalent alcohols having 2 to 8 carbon atoms such as ethylene glycol, propylene glycol, butylene glycol, hexylene glycol and glycerin
- the following polyhydric alcohols (E3) Glycol ethers having 4 to 12 carbon atoms such as diethylene glycol, triethylene glycol, tetraethylene glycol, dipropylene glycol and tripropylene glycol (E4) diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono Propyl ether, diethylene glycol monobutyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, tripropylene glycol monomethyl ether, 1-methoxy
- Component (E) is preferably one or more selected from diethylene glycol monobutyl ether, ethanol, ethylene glycol, propylene glycol, and butylene glycol from the viewpoint of stably blending component (C) and high-temperature storage stability. , and more preferably one or more selected from diethylene glycol monobutyl ether, ethylene glycol, and propylene glycol.
- the component (E) is preferably 1% by mass in the composition. Above, more preferably 3% by mass or more, still more preferably 5% by mass or more, and from the viewpoint of suppressing leakage of the functional agent from the silica capsule in component (A) and from the viewpoint of high-temperature storage stability, preferably 20% by mass % or less, more preferably 18 mass % or less, still more preferably 15 mass % or less.
- the composition of the present invention can further contain a pH adjuster as the component (F) from the viewpoint of suppressing precipitation or separation of solids in the composition in a low-temperature environment and high-temperature storage stability.
- a pH adjuster as the component (F) from the viewpoint of suppressing precipitation or separation of solids in the composition in a low-temperature environment and high-temperature storage stability.
- the component (F) excludes the pH adjuster included in the component (A).
- inorganic acids such as hydrochloric acid and sulfuric acid
- organic acids such as citric acid, succinic acid, malic acid, fumaric acid, tartaric acid, malonic acid and maleic acid
- acid agents such as p-toluenesulfonic acid and xylenesulfonic acid
- alkaline agents such as sodium carbonate and potassium carbonate such as sodium hydroxide, potassium hydroxide, ammonia and derivatives thereof, amine salts such as monoethanolamine, diethanolamine and triethanolamine.
- the component (F) is added to the composition from the viewpoint of suppressing precipitation or separation of solids in the composition in a low-temperature environment and high-temperature storage stability.
- the component (F) is added to the composition from the viewpoint of suppressing precipitation or separation of solids in the composition in a low-temperature environment and high-temperature storage stability.
- the product preferably 0.01% by mass or more, more preferably 0.03% by mass or more, still more preferably 0.05% by mass or more, and preferably 2% by mass or less, more preferably 1.5% by mass or less , more preferably 1.0% by mass or less.
- the balance of the composition of the invention is water.
- Water that is generally used for liquid cleaning agents is used, but deionized water (ion-exchanged water) or water added with sodium hypochlorite in an amount of 1 mg/kg or more and 5 mg/kg or less to the ion-exchanged water. can be used. Distilled water and tap water can also be used.
- the composition of the present invention preferably contains 50% by mass or more, more preferably 60% by mass or more, still more preferably 65% by mass or more, and preferably 99% by mass of water in the composition. .8% by mass or less, more preferably 95% by mass or less, still more preferably 90% by mass or less.
- composition of the present invention may contain the following components (G1) to (G7) within a range that does not impair the effects of the present invention. However, these components exclude those included in component (A).
- G1 Anti-soil redeposition agents and dispersants such as polyacrylic acid, polymaleic acid and carboxymethyl cellulose
- G2 Bleaching agents such as hydrogen peroxide, sodium percarbonate or sodium perborate
- G3 Tetraacetylethylenediamine, JP-A-6- Bleach activators (G4) such as bleach activators represented by general formulas (I-2) to (I-7) of No. 316700.
- One or more enzymes selected from cellulase, amylase, pectinase, protease and lipase are selected from cellulase, amylase, pectinase, protease and lipase.
- Fluorescent dyes for example, fluorescent dyes commercially available as Tinopal CBS (trade name, manufactured by Ciba Specialty Chemicals) and Whitex SA (trade name, manufactured by Sumitomo Chemical Co., Ltd.)
- G6 Butylhydroxytoluene, distyrenated cresol, sulfurous acid Antioxidants such as sodium and sodium hydrogen sulfite (G7), pigments, fragrances, antibacterial preservatives such as diclosan, antifoaming agents such as silicone
- the pH of the composition of the present invention at 25° C. is preferably 4 or more, more preferably 5 or more, and further preferably 4 or more, from the viewpoint of suppressing precipitation or separation of solids in the composition in a low-temperature environment and high-temperature storage stability. It is preferably 6 or more, preferably 9 or less, more preferably 8.5 or less, and even more preferably 8 or less.
- the pH is measured according to the pH measurement method described below.
- a pH meter (pH/ion meter D-71, manufactured by HORIBA) is connected to a combined electrode for pH measurement (9615S measurement method model JF15, manufactured by HORIBA), and the power is turned on.
- a saturated potassium chloride aqueous solution (3.33 mol/L) is used as the pH electrode internal liquid.
- pH 4.01 standard solution phthalate standard solution
- pH 6.86 neutral phosphate standard solution
- pH 9.18 standard solution bovine standard solution
- the pH measuring electrode is immersed in a standard solution adjusted to a constant temperature for 3 minutes, and calibrated in the order of pH 6.86 ⁇ pH 9.18 ⁇ pH 4.01.
- a sample to be measured is adjusted to 25° C., the electrode of the pH meter is immersed in the sample, and the pH is measured after 3 minutes.
- the viscosity at 25° C. of the composition of the present invention is preferably 10 mPa ⁇ s or more, more preferably 20 mPa ⁇ s or more, still more preferably 30 mPa ⁇ s or more, from the viewpoint of ease of handling and high-temperature storage stability. , preferably 400 mPa ⁇ s or less, more preferably 300 mPa ⁇ s or less, still more preferably 200 mPa ⁇ s or less.
- Brookfield viscometer (VISCOMETER MODEL DVM-B manufactured by Tokyo Keiki Co., Ltd.). 3 or 4, the number of revolutions was 60 r/min, and the measurement time was 60 seconds.
- composition of the present invention includes, for example, detergents, softeners, fiber treatment agents such as anti-wrinkle agents (e.g., spray-type anti-wrinkle agents), additives for sanitary products such as disposable diapers, fragrances, milky lotions, cosmetic liquids, and lotions. , serums, creams, gel preparations, hair treatment agents, cosmetics such as quasi-drugs, etc.
- fiber treatment agents such as anti-wrinkle agents (e.g., spray-type anti-wrinkle agents)
- additives for sanitary products such as disposable diapers, fragrances, milky lotions, cosmetic liquids, and lotions.
- serums, creams, gel preparations such as quasi-drugs, etc.
- composition of the present invention can be applied with modification as necessary. Also, the description of each aspect can be modified as necessary and applied to other aspects.
- component (A) functional agent-encapsulating silica capsule (B) component: a compound selected from silicic acid and silicates
- composition according to ⁇ 1> wherein the component (A) has a shell containing silica as a constituent and a core containing a functional agent inside the shell.
- the shell has a first shell and a second shell, and further has a first shell that encloses a core containing one or more functional agents, and a second shell that encloses the first shell. composition.
- the thickness of the shell is preferably 5 nm or more, preferably 20 nm or less, more preferably 15 nm or less, ⁇ 2> to ⁇ 4>
- ⁇ 6> The composition according to any one of ⁇ 2> to ⁇ 5>, wherein the shell (the first shell if it has the first shell and the second shell) is a dense layer having no pores.
- Component (A) has a first shell and a second shell, the thickness of the second shell is preferably 10 nm or more, more preferably 20 nm or more, and preferably 100 nm or less, more preferably 80 nm or less.
- the component (A) has a first shell and a second shell, and the second shell has a mesoporous structure in which silica is present in the direction along the interface with the first shell and in the thickness direction.
- the "mesoporous structure" in the second shell means that the diameter of pores (so-called mesopores) present in the structure preferably exceeds 2 nm, more preferably 10 nm or more, and further preferably
- the functional agent of component (A) is selected from fragrances, fragrance precursors, oils, antioxidants, cooling agents, warming agents, antibacterial agents, dyes, pigments, UV absorbers, silicones, solvents, and oil-soluble polymers. It is one or more kinds selected from fragrances, fragrance precursors, oils, antioxidants, cooling agents, warming agents, antibacterial agents, ultraviolet absorbers, and solvents.
- the volume average particle size of component (A) is preferably 0.5 ⁇ m or more, more preferably 0.7 ⁇ m or more, still more preferably 1 ⁇ m or more, and is preferably 50 ⁇ m or less, more preferably 10 ⁇ m or less, and still more preferably The composition according to any one of ⁇ 1> to ⁇ 10>, which is 5 ⁇ m or less.
- the component (A) has a first shell and a second shell containing silica as constituent components, and a core containing one or more functional agents inside the first shell, and the component (A) has the following The composition according to any one of ⁇ 1> to ⁇ 11>, which is obtained by a production method comprising steps (1) and (2).
- Step (1) An organic phase containing one or more functional agents and raw material silica (eg, tetraalkoxysilane) was mixed and emulsified in an aqueous phase containing a surfactant (eg, cationic surfactant). Then, a sol-gel reaction is performed under acidic conditions to form a shell to form capsules encapsulating the functional agent.
- the component (A) has a first shell and a second shell containing silica as constituent components, and a core containing one or more functional agents inside the first shell, and the component (A) has the following
- a surfactant e.g., a cationic surfactant
- ⁇ 14> The sol-gel reaction in steps (1) and (2), and steps (1a) and (2a) hydrolyzes and polycondenses raw material silica (silica precursor) under acidic conditions to give alcohol.
- the content of the functional agent is 5 mass% or more, further 10 mass% or more, further 12 mass% or more, and 50 mass% or less, further 45 mass% or less, further 40 mass% or less.
- the content of the functional agent encapsulating component (A) in the composition is preferably 0.02% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.1% by mass or more, and even more
- M2O.nSiO2.mH2O ( B1 ) [In the formula, M is an atom selected from an alkali metal atom and a hydrogen atom, n is a number of 1.0 or more and 4.0 or less, and m is a number of 5.0 or more and 50.0 or less. ]
- n is preferably a number of 1.8 to 4.0, more preferably 1.9 to 3.5, still more preferably 2.0 to 3.3, ⁇ 17 > or the composition according to ⁇ 18>.
- m is preferably a number of 10.0 to 48.0, more preferably 11.0 to 35.0, still more preferably 11.5 to 30.0, ⁇ 17 > to ⁇ 19>.
- Component (B) is sodium silicate (sodium silicate), and is further selected from No. 1 sodium silicate, No. 2 sodium silicate, No. 3 sodium silicate, No. 4 sodium silicate, and No. 5 sodium silicate.
- Component (B) in the composition is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, still more preferably 0.05% by mass or more, and even more preferably 0.15% by mass or more;
- composition according to any one of ⁇ 1> to ⁇ 24> further comprising the following component (C).
- Component (C) is one or more surfactants selected from (C1) anionic surfactants (hereinafter referred to as component (C1)) and (C2) nonionic surfactants, and (C2) nonionic surfactants.
- component (C1) anionic surfactants
- component (C2) nonionic surfactants
- component (C2) nonionic surfactants
- component (C2) active agents
- C1 component anionic surfactant selected from sulfonic acids having a hydrocarbon group and salts thereof, sulfuric acid esters having a hydrocarbon group and salts thereof, and carboxylic acids having a hydrocarbon group and salts thereof;
- the active agent is an anionic surfactant selected from sulfonates having a hydrocarbon group and carboxylates having a hydrocarbon group.
- composition according to ⁇ 27> wherein the hydrocarbon group is an alkyl group or an alkenyl group.
- the number of carbon atoms in the hydrocarbon group is 3 or more, preferably 7 or more, more preferably 9 or more, still more preferably 11 or more, and preferably 22 or less, more preferably 20 or less, and still more preferably 18 or less.
- the salt of the anionic surfactant is monovalent metal salt such as sodium salt or potassium salt, divalent metal salt such as magnesium salt, organic amine salt such as ammonium salt, monoethanolamine salt, diethanolamine salt or triethanolamine salt.
- Component (C1) is one or more anionic surfactants selected from components (c1-1) to (c1-5) below, and one or more anions selected from component (c1-1) below.
- (c1-1) component a sulfonic acid represented by the following general formula (c1-1) or a salt thereof R 1 -B-SO 3 M (c1-1)
- R 1 represents an alkyl group or alkenyl group having 3 to 21 carbon atoms
- B represents a benzene ring
- M represents a hydrogen atom, an alkali metal, an alkaline earth metal (1/2 atom), ammonium, or organic ammonium.
- the sulfonic acid group is attached at the ortho-, meta- or para-position relative to R1 , which is attached to B.
- component salt of internal olefin sulfonic acid having 14 to 24 carbon atoms
- component salt of fatty acid having 8 to 20 carbon atoms
- component the following general formula (c1- 4) a sulfuric acid ester or a salt thereof
- R 2 represents an alkyl or alkenyl group having 8 to 22 carbon atoms, the carbon atom bonded to the oxygen atom is the first carbon atom
- PO is a propyleneoxy group
- EO represents an ethyleneoxy group
- EO and PO may be block or random bonds
- / is a symbol indicating that the bonding order of PO and EO does not matter
- m and n are the average number of added moles, , m is 0 or more and 5 or less, n is 0 or more and 16 or less, and M represents a hydrogen atom,
- Component (c1-5) an ⁇ -sulfofatty acid ester represented by the following general formula (c1-5) or a salt thereof R 3 —CH(SO 3 M)COOR 4 (c1-5)
- R 3 represents an alkyl group or alkenyl group having 6 to 20 carbon atoms
- R 4 represents an alkyl group having 1 to 6 carbon atoms
- M represents a hydrogen atom, an alkali metal, Indicates an alkaline earth metal (1/2 atom), ammonium or organic ammonium.
- the number of carbon atoms in R 1 is 3 or more, preferably 5 or more, more preferably 6 or more, still more preferably 7 or more, and 21 or less, preferably 20 or less, more preferably 19 or less. , and more preferably 18 or less, the composition according to ⁇ 31>.
- M is an alkali metal or an organic ammonium, and further is sodium.
- component (c1-1) is a surfactant selected from alkyl (4 or more carbon atoms) benzenesulfonic acid and cumenesulfonic acid.
- the number of carbon atoms in the internal olefin sulfonate of component (c1-2) is 14 or more, preferably 16 or more, more preferably 18 or more, and 24 or less, more preferably 22 or less, and still more preferably 20 or less.
- Salts of component (c1-2) are alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, ammonium salts and organic ammonium salts such as monoethanolammonium, diethanolammonium and triethanolammonium.
- Component fatty acid has 8 or more, preferably 10 or more, more preferably 12 or more carbon atoms, and 20 or less, more preferably 18 or less, still more preferably 16 or less, ⁇ 31>- The composition according to any one of ⁇ 33>.
- ⁇ 39> (c1-3) fatty acid whose component is selected from octanoate, decanoate, laurate, myristate, palmitate, stearate, coconut fatty acid salt, palm fatty acid salt, and palm kernel fatty acid salt
- c1-3 fatty acid whose component is selected from octanoate, decanoate, laurate, myristate, palmitate, stearate, coconut fatty acid salt, palm fatty acid salt, and palm kernel fatty acid salt
- R 2 has 8 or more carbon atoms, preferably 9 or more, more preferably 10 or more, more preferably 12 or more, and 22 or less, preferably 18 or less, more preferably 16 or less,
- n is 0 or more, preferably 1 or more, more preferably 2 or more, still more preferably 4 or more, and preferably 10 or less, more preferably 8 or less, still more preferably 6 or less.
- M is preferably a hydrogen atom, an alkali metal such as sodium or potassium, an alkaline earth metal (1/2 atom) such as magnesium or calcium, or an organic ammonium, more preferably sodium,
- an alkali metal such as sodium or potassium
- an alkaline earth metal such as magnesium or calcium
- an organic ammonium more preferably sodium
- Component (c1-4) has an alkyl group having 12 to 14 carbon atoms, an average added mole number of propioxy groups of 0 to 4, and an average added mole number of ethyleneoxy groups of 1 to 4
- component (c1-4) is an alkyl group having 12 to 14 carbon atoms in general formula (c1-4)
- m is The composition according to any one of ⁇ 31> to ⁇ 43>, wherein the compound is 0 or more and 4 or less, n is 1 or more and 4 or less, and M is sodium.
- R 3 is an alkyl or alkenyl group having 6 or more, preferably 8 or more, more preferably 10 or more carbon atoms and 20 or less, preferably 18 or less, more preferably 16 or less carbon atoms.
- R 4 is an alkyl group having 1 or more, preferably 5 or less, more preferably 4 or less carbon atoms.
- M is preferably a hydrogen atom, an alkali metal such as sodium or potassium, an alkaline earth metal (1/2 atom) such as magnesium or calcium, or an organic ammonium, more preferably sodium,
- an alkali metal such as sodium or potassium
- an alkaline earth metal such as magnesium or calcium
- an organic ammonium more preferably sodium
- Component (c1-5) is ⁇ -sulfo fatty acid methyl ester sodium or a salt thereof wherein R 3 is an alkyl group of 11 or more and 14 or less and R 4 is a methyl group in formula (c1-5) ⁇ 31> The composition according to any one of ⁇ 47>.
- the (C2) component nonionic surfactant is sucrose fatty acid ester, glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyalkylene sorbitan fatty acid ester, polyoxyalkylene fatty acid ester, fatty acid alkanolamide or its alkylene oxide adduct, polyoxyalkylene alkyl.
- R 5 is an alkyl group or alkenyl group having 9 to 18 carbon atoms
- R 6 is a hydrogen atom or a methyl group
- CO is a carbonyl group
- x is the number of 0 or 1
- AO is one or more alkyleneoxy groups selected from alkyleneoxy groups having 2 to 4 carbon atoms; When AO contains two or more alkyleneoxy groups, it may be a random bond or a block bond.
- the number of carbon atoms in R 5 is 9 or more, preferably 10 or more, more preferably 11 or more, still more preferably 12 or more, and 17 or less, preferably 16 or less, more preferably 15 or less. , and more preferably 14 or less, the composition according to ⁇ 50>.
- AO is one or more alkyleneoxy groups selected from an ethyleneoxy group and a propyleneoxy group.
- y is 3 or more, preferably 5 or more, more preferably 7 or more, still more preferably 8 or more, even more preferably 9 or more, still more preferably 10 or more, and 50 or less,
- Component (C) in the composition is preferably 1% by mass or more, more preferably 2% by mass or more, still more preferably 5% by mass or more, still more preferably 10% by mass or more, and even more preferably 20% by mass or more. , and preferably 40% by mass or less, more preferably 35% by mass or less, and still more preferably 30% by mass or less, the composition according to any one of ⁇ 25> to ⁇ 56>.
- ⁇ 58> (C)/(A), which is the mass ratio of the content of component (A) as a functional agent to be encapsulated and the content of component (C), is preferably 0 or more, more preferably 5 or more, and even more preferably 10 or more, still more preferably 25 or more, still more preferably 50 or more, still more preferably 90 or more, and preferably 1000 or less, more preferably 700 or less, even more preferably 500 or less, still more preferably 200 or less
- composition according to any one of ⁇ 1> to ⁇ 58> further comprising the following component (D).
- Component (D) in the composition is 0.05% by mass or more, further 0.07% by mass or more, further 0.1% by mass or more, and 1% by mass or less, further 0.8% by mass or less, and further 0
- composition according to any one of ⁇ 1> to ⁇ 60> as a fiber treatment agent, additive for sanitary products, or cosmetics.
- ⁇ 62> The use according to ⁇ 61>, wherein the fiber treatment agent is a detergent, softener, or anti-wrinkle agent.
- sanitary product additive is a disposable diaper additive.
- the cosmetics are one or more selected from fragrances, milky lotions, cosmetic liquids, lotions, serums, creams, gel formulations, hair treatment agents, and quasi-drugs. Use as described in any.
- composition according to any one of ⁇ 1> to ⁇ 60> as a fiber treatment agent, additive for sanitary products, or cosmetics.
- the fiber treatment agent is one or more selected from detergents, softeners, and anti-wrinkle agents.
- sanitary product additive is a disposable diaper additive.
- the cosmetics are one or more selected from fragrances, milky lotions, lotions, lotions, beauty essences, creams, gel preparations, hair treatment agents, and quasi-drugs. Any use described.
- compositions shown in Tables 2 to 6 were prepared using the following ingredients, and storage stability and the like were evaluated by the following methods using the obtained compositions.
- an oil phase component prepared by mixing 200 g of model perfume A1 in the blending ratio shown in Table 1 and 50 g of tetraethoxysilane (hereinafter also referred to as "TEOS") was added, and a homomixer (manufactured by HsiangTai) was added.
- TEOS tetraethoxysilane
- HsiangTai tetraethoxysilane
- model: HM-310 hereinafter the same
- the volume average particle diameter of the emulsified droplets at this time was 1.4 ⁇ m.
- Step (2) While stirring the aqueous dispersion obtained in step 1 at a liquid temperature of 30° C., 21 g of TEOS was added dropwise over 420 minutes. After the dropwise addition, stirring was continued for 17 hours, followed by cooling to form a second shell that encloses the first shell, and a silica capsule (model perfume A1 (functional agent ) content of 19.4% by mass in the silica capsule) was obtained.
- the volume average particle size of the silica capsule was 2.1 ⁇ m.
- the volume average particle diameters of the emulsified droplets and silica capsules (I) were measured using a laser diffraction/scattering particle size distribution analyzer “LA-960” (trade name, manufactured by HORIBA, Ltd.).
- a flow cell was used for the measurement, the medium was water, and the refractive index was set to 1.40-0i.
- An emulsified liquid or an aqueous dispersion containing silica capsules was added to the flow cell, and the measurement was performed at a concentration at which the transmittance was around 90%, and the volume average particle diameter was determined on a volume basis (of the other (A) component
- the method for measuring the volume average particle diameter is the same).
- the thickness of the first shell was approximately 5 nm, and the thickness of the second shell was 5 to 30 nm.
- the model perfume A1 used was a perfume having the composition shown in Table 1 below (volume average ClogP: 3.9, specific gravity: 0.96).
- the volume average ClogP value of the model perfume A1 was always calculated as the sum of the ClogP values of the perfume components contained in the model perfume A1 and the respective volume fractions in the model perfume A1. In this calculation, all perfume ingredients whose content in the model perfume A1 is 0.5% by mass or more are considered, and even for perfume ingredients whose content in the model perfume A1 is less than 0.5% by mass, the specific gravity and Those with clear ClogP values were included in the calculation.
- ⁇ A-2 Fragrance-encapsulating silica capsule obtained by the following method 2 [Method 2]
- An aqueous solution was prepared by diluting 1.80 g of the trade name "Cortamine 60W” (manufactured by Kao Corporation; cetyltrimethylammonium chloride, effective content: 30% by mass) with 448.20 g of deionized water.
- an oil phase prepared by mixing 120 g of model fragrance A2 and 30 g of tetraethoxysilane (TEOS) was added, and the mixture was emulsified using a homomixer set at 8500 rpm.
- TEOS tetraethoxysilane
- model perfume A2 (functional agent) was 20% by mass in the silica capsules) was obtained.
- the composition of model perfume A2 was 25% by mass of Limonene, 25% by mass of Methyl-iso-eugenol, and 50% by mass of ⁇ -Hexylcinnamaldehyde.
- ⁇ A-3 Silica capsules containing a cooling sensation imparting agent obtained by the following method 3 [Method 3] Step (1) An aqueous solution was prepared by diluting 0.90 g of the trade name "Cortamine 60W” (manufactured by Kao Corporation; cetyltrimethylammonium chloride, effective content: 30% by mass) with 224.10 g of deionized water. To this aqueous solution, an oil phase prepared by mixing 60 g of a cooling agent and 15 g of tetraethoxysilane (TEOS) was added, and the mixture was emulsified using a homomixer set at 8500 rpm.
- TEOS tetraethoxysilane
- Step (2) After adjusting the pH to 3.7 using 1 wt% sulfuric acid, the solution was transferred to a separable flask equipped with a stirring blade and a cooler, and stirred at 160 rpm for 24 hours while maintaining the liquid temperature at 30°C.
- Step (2) 9.0 g of TEOS was added dropwise over 420 minutes while the liquid temperature was kept at 30° C. and the pH of the suspension was 3.7. After the dropwise addition, stirring was continued for 24 hours, followed by cooling, whereby silica capsules with a volume average particle size of 1.4 ⁇ m encapsulated with amorphous silica (the content of the cooling sensation imparting agent (functional agent) was reduced to silica capsules A suspension containing 20% by weight in the medium was obtained.
- the composition of the cooling sensation imparting agent was 60% by mass of L-menthol, 10% by mass of isopropyl myristate, and 30% by mass of hexyl salicylate.
- ⁇ A-4 Silica capsule containing an ultraviolet absorber (content of ultraviolet absorber (functional agent) is 37% by mass in silica capsule), Merck Co. Eusolex UV-Pearls OB-S (product name)
- B-4 Sodium silicate (No.
- C-1 sodium polyoxyethylene dodecyl ether sulfate (average number of added moles of ethylene oxide (hereinafter EO): 3)
- EO polyoxyethylene lauryl ether
- C-3 Internal olefin sulfonic acid potassium salt having 18 carbon atoms.
- the mass ratio of olefin (potassium olefinsulfonate)/hydroxy (potassium hydroxyalkanesulfonate) in C-3 is 16/84.
- the mass ratio of the position distribution of the sulfonic acid group in the hydroxy form in C-3 is as follows.
- (IO-1S)/(IO-2S) 1.6 (mass ratio).
- (IO-1S)/(IO-2S) is the content of the internal olefin sulfonate (IO-1S) in which the sulfonic acid group is present at the 2- to 4-positions in C-3 and the sulfone It is a mass ratio to the content of internal olefin sulfonate (IO-2S) having an acid group at the 5th or higher position.
- LC-MS liquid chromatograph-mass spectrometer
- LC device "LC-20ASXR” (manufactured by Shimadzu Corporation)
- LC-MS device "LCMS-2020” (manufactured by Shimadzu Corporation)
- Detector: ESI (-), m/z 349.15 (C18), 321.10 (C16), 293.05 (C14)
- Solvent A 10 mM ammonium acetate aqueous solution
- ⁇ C-5 Polyoxyalkylene lauryl ether (per 1 mol of lauryl alcohol, 9 mol of EO on average was added, 2 mol of propylene oxide (hereinafter referred to as PO) was added on average, and 9 mol of EO was added on average.
- PO propylene oxide
- ⁇ C-6 Polyoxyalkylene lauryl ether (a compound obtained by adding an average of 3.7 moles of PO and adding an average of 16.5 moles of EO to 1 mole of lauryl alcohol)
- ⁇ C-7 polyoxyethylene lauryl ether (average number of added moles of EO: 8.3 mol)
- C-8 polyoxyethylene lauryl ether (average number of added moles of EO: 13.2 mol)
- ⁇ C-9 polyoxyethylene lauryl ether (average number of added moles of EO: 18.5 mol)
- ⁇ Method for preparing composition> components other than the components (A) and (B) among the ingredients shown in the table were mixed at a predetermined ratio. After that, the component (B) was mixed and then the component (A) was mixed to prepare the compositions shown in the table. At that time, for A-1 to A-3, the aqueous dispersions or suspensions obtained in Methods 1 to 3 are included, and for A-4, the product is in its actual form, and the component (A) (silica capsule) is included. It was used so that the blending amount as a functional agent to be used was the mass % shown in the table. That is, the mass % and mass ratio of component (A) in the table are based on the amount of the functional agent. The pH (25° C.) of the composition was adjusted to the value shown in the table using a pH adjuster as appropriate. In the table, "+" in the blending amount of the pH adjuster means that the pH of the composition is adjusted to a predetermined value.
- the content of component (B) in the table is the content as silicon dioxide (SiO 2 ) and was quantified by the following method.
- This sample was subjected to ICP emission spectrometry using iCAP6500Duo manufactured by Thermo Fisher Scientific Co., Ltd. to calculate salt dissolved in the dough as SiO 2 .
- a calibration curve was prepared using samples to which a silicon standard solution (1000 ppm) was diluted and the same amount of alkaline flux was added.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Textile Engineering (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Fats And Perfumes (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/720,904 US20250066693A1 (en) | 2021-12-23 | 2022-11-28 | Composition |
| CN202280084705.9A CN118450937A (zh) | 2021-12-23 | 2022-11-28 | 组合物 |
| EP22910758.6A EP4454715A4 (en) | 2021-12-23 | 2022-11-28 | COMPOSITION |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-209133 | 2021-12-23 | ||
| JP2021209133 | 2021-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023120040A1 true WO2023120040A1 (ja) | 2023-06-29 |
Family
ID=86902058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2022/043646 Ceased WO2023120040A1 (ja) | 2021-12-23 | 2022-11-28 | 組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250066693A1 (https=) |
| EP (1) | EP4454715A4 (https=) |
| JP (1) | JP2023094561A (https=) |
| CN (1) | CN118450937A (https=) |
| TW (1) | TW202329907A (https=) |
| WO (1) | WO2023120040A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4269550A4 (en) * | 2020-12-28 | 2025-03-26 | Kao Corporation | PROCESS FOR MANUFACTURING SILICA MICROCAPSULES |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06316700A (ja) | 1993-03-11 | 1994-11-15 | Kao Corp | 漂白剤組成物及び漂白洗浄剤組成物 |
| JPH114802A (ja) | 1997-06-17 | 1999-01-12 | Asahi Optical Co Ltd | 内視鏡の焦点調節装置 |
| JP2001032172A (ja) * | 1999-07-12 | 2001-02-06 | Seiichi Sano | 蓬入り繊維シート |
| JP2009504812A (ja) | 2005-08-10 | 2009-02-05 | ヘンケル・アクチェンゲゼルシャフト・ウント・コムパニー・コマンディットゲゼルシャフト・アウフ・アクチェン | 易溶性カプセルを含んでなる洗剤および洗浄剤 |
| JP2010120863A (ja) * | 2008-11-17 | 2010-06-03 | Agc Si-Tech Co Ltd | 人体用デオドラント剤 |
| JP2011517323A (ja) | 2008-02-27 | 2011-06-02 | ダウ・コーニング・コーポレイション | 界面活性剤を含有する組成物における親油性活性材料の堆積 |
| JP2015128762A (ja) | 2013-12-06 | 2015-07-16 | 花王株式会社 | マイクロカプセルの製造方法 |
| JP2017114802A (ja) | 2015-12-22 | 2017-06-29 | 花王株式会社 | マイクロカプセル及びその製造方法 |
| US20200352832A1 (en) * | 2019-05-06 | 2020-11-12 | Colgate-Palmolive Company | Oral Care Compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6271560B2 (ja) * | 2012-09-20 | 2018-01-31 | アプヴィオン インコーポレイテッド | 噴霧乾燥マイクロカプセル |
-
2022
- 2022-11-28 TW TW111145430A patent/TW202329907A/zh unknown
- 2022-11-28 WO PCT/JP2022/043646 patent/WO2023120040A1/ja not_active Ceased
- 2022-11-28 US US18/720,904 patent/US20250066693A1/en active Pending
- 2022-11-28 EP EP22910758.6A patent/EP4454715A4/en active Pending
- 2022-11-28 CN CN202280084705.9A patent/CN118450937A/zh active Pending
- 2022-11-28 JP JP2022188898A patent/JP2023094561A/ja active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06316700A (ja) | 1993-03-11 | 1994-11-15 | Kao Corp | 漂白剤組成物及び漂白洗浄剤組成物 |
| JPH114802A (ja) | 1997-06-17 | 1999-01-12 | Asahi Optical Co Ltd | 内視鏡の焦点調節装置 |
| JP2001032172A (ja) * | 1999-07-12 | 2001-02-06 | Seiichi Sano | 蓬入り繊維シート |
| JP2009504812A (ja) | 2005-08-10 | 2009-02-05 | ヘンケル・アクチェンゲゼルシャフト・ウント・コムパニー・コマンディットゲゼルシャフト・アウフ・アクチェン | 易溶性カプセルを含んでなる洗剤および洗浄剤 |
| JP2011517323A (ja) | 2008-02-27 | 2011-06-02 | ダウ・コーニング・コーポレイション | 界面活性剤を含有する組成物における親油性活性材料の堆積 |
| JP2010120863A (ja) * | 2008-11-17 | 2010-06-03 | Agc Si-Tech Co Ltd | 人体用デオドラント剤 |
| JP2015128762A (ja) | 2013-12-06 | 2015-07-16 | 花王株式会社 | マイクロカプセルの製造方法 |
| JP2017114802A (ja) | 2015-12-22 | 2017-06-29 | 花王株式会社 | マイクロカプセル及びその製造方法 |
| US20200352832A1 (en) * | 2019-05-06 | 2020-11-12 | Colgate-Palmolive Company | Oral Care Compositions |
Non-Patent Citations (2)
| Title |
|---|
| A. LEO: "Comprehensive Medicinal Chemistry", vol. 4, 1990, PERGAMON PRESS, pages: 295 |
| See also references of EP4454715A4 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023094561A (ja) | 2023-07-05 |
| TW202329907A (zh) | 2023-08-01 |
| CN118450937A (zh) | 2024-08-06 |
| US20250066693A1 (en) | 2025-02-27 |
| EP4454715A1 (en) | 2024-10-30 |
| EP4454715A4 (en) | 2025-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7688120B2 (ja) | 洗濯物ケア添加剤粒子 | |
| EP2711414B1 (de) | Stabilisierug von Kapselsystemen in Wasch- und Reinigungsmitteln | |
| ES3055160T3 (en) | Liquid fabric care compositions comprising capsules | |
| US12129448B2 (en) | Water-soluble unit dose article containing a core/shell capsule | |
| US10538631B2 (en) | Benefit agent containing delivery particle | |
| TW202330889A (zh) | 清潔劑組合物 | |
| WO2019030393A1 (en) | PHOTOSENSITIVE MICROCAPSULES | |
| WO2023120040A1 (ja) | 組成物 | |
| JP7184630B2 (ja) | 洗濯用液体組成物 | |
| JP7725356B2 (ja) | 繊維の処理方法 | |
| JP7813135B2 (ja) | 洗浄剤組成物 | |
| WO2023200771A1 (en) | Fabric care unit dose articles with capsules | |
| DE102016219296A1 (de) | Parfümhaltige Schmelzkörper | |
| JP2024179018A (ja) | 有益成分の繊維製品への吸着性を向上させる方法及び繊維製品処理剤組成物 | |
| WO2018055124A1 (de) | Schnelllösliche, parfümhaltige schmelzkörper | |
| JP2025009920A (ja) | マイクロカプセル含有アニオン性界面活性剤組成物の製造方法 | |
| JP2024009582A (ja) | 繊維製品処理剤組成物 | |
| WO2018055112A1 (de) | Parfümhaltige schmelzkörper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22910758 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 18720904 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2401004036 Country of ref document: TH |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280084705.9 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2022910758 Country of ref document: EP Effective date: 20240723 |
|
| WWP | Wipo information: published in national office |
Ref document number: 18720904 Country of ref document: US |